SUBSCRIBE BY RSS rss feed | EMAIL
Natural Solutions Radio header image

Crohn

FDA Approves New Crohn's Disease Treatment

February 28th 2007
by News Staff

The U.S. Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's disease.

The FDA described Crohn's disease as a chronic, incurable, inflammatory bowel disease that causes diarrhea, cramping and abdominal pain and in some cases, abnormal connections (fistulas) leading from the intestine to the skin. It affects an estimated 1 million Americans.

Topics: